IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,604 | -37.7% | 16,200 | 0.0% | 0.02% | -40.0% |
| Q2 2023 | $115,020 | +11.1% | 16,200 | 0.0% | 0.02% | -35.9% |
| Q4 2022 | $103,519 | -31.9% | 16,200 | 0.0% | 0.04% | +5.4% |
| Q3 2022 | $152,000 | -18.3% | 16,200 | 0.0% | 0.04% | -9.8% |
| Q2 2022 | $186,000 | -65.5% | 16,200 | -50.0% | 0.04% | -61.0% |
| Q1 2022 | $539,000 | +73.9% | 32,400 | +100.0% | 0.10% | +94.4% |
| Q4 2021 | $310,000 | -28.4% | 16,200 | 0.0% | 0.05% | -31.6% |
| Q3 2021 | $433,000 | +4.3% | 16,200 | 0.0% | 0.08% | -2.5% |
| Q2 2021 | $415,000 | -17.3% | 16,200 | 0.0% | 0.08% | -23.6% |
| Q1 2021 | $502,000 | -38.8% | 16,200 | 0.0% | 0.11% | -43.3% |
| Q4 2020 | $820,000 | +58.3% | 16,200 | 0.0% | 0.19% | +32.6% |
| Q3 2020 | $518,000 | – | 16,200 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |